Skip to main content

Find Clinical Trials

Home
Conditions
Mesothelioma

Clinical trial condition

Mesothelioma

Explore clinical trials studying Mesothelioma. Study availability and eligibility vary by location and protocol.

141 public trials 37 recruiting studies

Refine in advanced search Browse all conditions

Mesothelioma trial results

Completed

Phase I Trial HIPEC With Nal-irinotecan

NCT04088786

Conditions: Adenocarcinoma, Adenocarcinoma, Mucinous, Adenoma, +26 more
Locations: University of Kentucky Lexington, Kentucky, United States

Stony Brook University Cancer Center Stony Brook, New York, United States

View Trial Details

Completed

First-in-human Study of S-588210 (S-488210+S-488211)

NCT04316689

Conditions: Adenoma, Bladder Cancer, Digestive System Diseases, +33 more
Locations: University College London Clinical Research Facility London, United Kingdom

View Trial Details

Completed

Intravenous Magnesium in Patients Receiving Cisplatin

NCT04481672

Conditions: Adenoma, Mesothelioma, Neoplasms, +3 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

View Trial Details

Completed

A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies

NCT03652077

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +96 more
Locations: The Angeles Clinical and Research Institute Los Angeles, California, United States

University of Mississippi Jackson, Mississippi, United States

Hackensack Medical Center Hackensack, New Jersey, United States

Carolina BioOncology Huntsville, North Carolina, United States

View Trial Details

Completed

Vinorelbine in Mesothelioma

NCT02139904

Conditions: Adenoma, Mesothelioma, Neoplasms, +3 more
Locations: Wales Cancer Trials Unit Cardiff, United Kingdom

View Trial Details

Completed

Study of the EZH2 Inhibitor Tazemetostat in Malignant Mesothelioma

NCT02860286

Conditions: Adenoma, BAP1 Loss of Function, Mesothelioma, +4 more
Locations: University of California, Los Angeles Los Angeles, California, United States

City of Hope National Medical Center Los Angeles, California, United States

University of California San Francisco San Francisco, California, United States

Massachusetts General Hospital Boston, Massachusetts, United States

View all 16 locations

View Trial Details

Completed

Olaparib in People With Malignant Mesothelioma

NCT03531840

Conditions: Adenoma, Mesothelioma, Neoplasms, +3 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Nivolumab Monotherapy or Nivolumab Plus Ipilimumab, for Unresectable Malignant Pleural Mesothelioma (MPM) Patients

NCT02716272

Conditions: Adenoma, Mesothelioma, Neoplasms, +3 more
Locations: Angers - CHU Angers, France

Avignon - Institut Sainte-Catherine Avignon, France

CHU Clermont-Ferrand, France

Dijon - CHU Dijon, France

View all 22 locations

View Trial Details

Completed

Pharmacokinetic, Safety, and Efficacy Effects of Oral LBH589 on Dextromethorphan in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer or Malignant Pleural Mesothelioma

NCT00535951

Conditions: Adenoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +14 more
Locations: Highlands Oncology Group Fayetteville, Arkansas, United States

Medical College of Georgia Augusta, Georgia, United States

RUSH Medical Center Chicago, Illinois, United States

MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Phase II Anetumab Ravtansine as 2nd Line Treatment for Malignant Pleural Mesothelioma (MPM)

NCT02610140

Conditions: Adenoma, Mesothelioma, Neoplasms, +3 more
Locations: La Jolla, California, United States

Aurora, Colorado, United States

Norwich, Connecticut, United States

Tampa, Florida, United States

View all 75 locations

View Trial Details